ClinicalTrials.Veeva

Menu

Comparison of The Success Rates of Four Different Pulpotomy Techniques

I

Istanbul University

Status and phase

Completed
Phase 3

Conditions

Extensive Decay in Primary Molars

Treatments

Drug: MTA Plus
Drug: ProRoot (Aggregate)
Drug: Biodentine
Drug: Ferric Sulfate 20 % Dental Gel

Study type

Interventional

Funder types

Other

Identifiers

NCT03135626
2012/1728-1288

Details and patient eligibility

About

This randomized clinical trial was conducted to examine and compare the effectiveness of pulpotomy in primary molars treated with calcium silicate based materials including Biodentine and two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®). Ferric sulfate pulpotomy was selected to represent the control group. 116 primary molars in 29 children were treated by pulpotomy and followed for a period of 24 months.

Enrollment

38 patients

Sex

All

Ages

5 to 7 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients were eligible if they were 5 to 7 years old, healthy and cooperative, and had at least four carious primary molars, each of which was in a different quadrant and required a pulpotomy. The criteria for the selection of the teeth to be included in the study were presence of deep caries, presence of at least two-thirds of the root length radiographically and being restorable.

Exclusion criteria

  • The exclusion criteria were the presence of any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL) space, furcal or periapical radiolucency and teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure. Teeth without permanent successor were not also included in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

38 participants in 4 patient groups

Biodentine
Experimental group
Description:
Biodentine pulpotomy agent
Treatment:
Drug: Biodentine
ProRoot MTA
Experimental group
Description:
ProRoot MTA pulpotomy agent
Treatment:
Drug: ProRoot (Aggregate)
MTA Plus
Experimental group
Description:
MTA Plus pulpotomy agent
Treatment:
Drug: MTA Plus
Ferric Sulfate 20% Dental Gel
Active Comparator group
Description:
Ferric Sulfate %20 Dental Gel pulpotomy agent
Treatment:
Drug: Ferric Sulfate 20 % Dental Gel

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems